Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A412WV | ISIN: US80880W2052 | Ticker-Symbol:
NASDAQ
02.09.25 | 22:00
18,640 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SCILEX HOLDING COMPANY Chart 1 Jahr
5-Tage-Chart
SCILEX HOLDING COMPANY 5-Tage-Chart

Aktuelle News zur SCILEX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SCILEX Aktie jetzt für 0€ handeln
21.08.Scilex CEO to resign as focus turns to Semnur - Denali merger11
21.08.Scilex Holding Co - 8-K, Current Report2
21.08.Scilex subsidiary Semnur secures $20 million for pain drug development1
21.08.Scilex-Tochter Semnur sichert sich 20 Millionen US-Dollar für Schmerzmittelentwicklung2
21.08.Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. ("Semnur"), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement ...2
13.08.Scilex stock jumps after SEC declares S-4 effective for Semnur merger17
13.08.Scilex subsidiary Semnur moves forward with Denali merger13
13.08.Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc.138Denali's registration statement on Form S-4 declared effective by the Securities and Exchange CommissionExtraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the...
► Artikel lesen
04.08.Scilex files to sell 1.39M shares of common stock for holders10
04.08.Scilex Holding Co - S-1, General form for registration of securities3
23.07.Scilex Holding Co - 8-K, Current Report12
23.06.Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May ...11
23.06.Scilex Holding Co - 8-K, Current Report4
05.06.Scilex announces dosing guide for gout medication GLOPERBA3
05.06.Scilex Holding Company Announces Publication on GLOPERBA Dosing Adjustments in Peer-Review Journal6
04.06.Scilex Holding Co - 8-K, Current Report4
16.05.Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional .21
14.05.Scilex Holding Co - 10-Q, Quarterly Report6
12.05.Scilex Holding Co - 8-K, Current Report2
01.05.Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of ...20
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1